These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 14666716)

  • 1. Combined effects of resveratrol and paclitaxel on lung cancer cells.
    Kubota T; Uemura Y; Kobayashi M; Taguchi H
    Anticancer Res; 2003; 23(5A):4039-46. PubMed ID: 14666716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of p21WAF1/CIP1, pRB, Bax and NF-kappaB in induction of growth arrest and apoptosis by resveratrol in human lung carcinoma A549 cells.
    Kim YA; Lee WH; Choi TH; Rhee SH; Park KY; Choi YH
    Int J Oncol; 2003 Oct; 23(4):1143-9. PubMed ID: 12963997
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
    Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
    J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro sequence-dependent synergism between paclitaxel and gefitinib in human lung cancer cell lines.
    Cheng H; An SJ; Zhang XC; Dong S; Zhang YF; Chen ZH; Chen HJ; Guo AL; Lin QX; Wu YL
    Cancer Chemother Pharmacol; 2011 Mar; 67(3):637-46. PubMed ID: 20495920
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel signaling molecules implicated in tumor-associated fatty acid synthase-dependent breast cancer cell proliferation and survival: Role of exogenous dietary fatty acids, p53-p21WAF1/CIP1, ERK1/2 MAPK, p27KIP1, BRCA1, and NF-kappaB.
    Menendez JA; Mehmi I; Atlas E; Colomer R; Lupu R
    Int J Oncol; 2004 Mar; 24(3):591-608. PubMed ID: 14767544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to epidermal growth factor receptor inhibitors in non-small cell lung cancer cells: limited antiproliferative effects and absence of apoptosis associated with persistent activity of extracellular signal-regulated kinase or Akt kinase pathways.
    Janmaat ML; Kruyt FA; Rodriguez JA; Giaccone G
    Clin Cancer Res; 2003 Jun; 9(6):2316-26. PubMed ID: 12796401
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decrease in susceptibility toward induction of apoptosis and alteration in G1 checkpoint function as determinants of resistance of human lung cancer cells against the antisignaling drug UCN-01 (7-Hydroxystaurosporine).
    Sugiyama K; Akiyama T; Shimizu M; Tamaoki T; Courage C; Gescher A; Akinaga S
    Cancer Res; 1999 Sep; 59(17):4406-12. PubMed ID: 10485490
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The proliferative inhibition and apoptotic mechanism of Saikosaponin D in human non-small cell lung cancer A549 cells.
    Hsu YL; Kuo PL; Lin CC
    Life Sci; 2004 Jul; 75(10):1231-42. PubMed ID: 15219811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tamoxifen induces p21WAF1 and p27KIP1 expression in estrogen receptor-negative lung cancer cells.
    Lee TH; Chuang LY; Hung WC
    Oncogene; 1999 Jul; 18(29):4269-74. PubMed ID: 10435640
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HY253, a novel decahydrofluorene analog, from Aralia continentalis, induces cell cycle arrest at the G1 phase and cytochrome c-mediated apoptosis in human lung cancer A549 cells.
    Oh HL; Lee DK; Lim H; Lee CH
    J Ethnopharmacol; 2010 May; 129(1):135-9. PubMed ID: 20219657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic suppression of microtubule dynamics by discodermolide and paclitaxel in non-small cell lung carcinoma cells.
    Honore S; Kamath K; Braguer D; Horwitz SB; Wilson L; Briand C; Jordan MA
    Cancer Res; 2004 Jul; 64(14):4957-64. PubMed ID: 15256469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. p53-independent apoptosis induced by genistein in lung cancer cells.
    Lian F; Li Y; Bhuiyan M; Sarkar FH
    Nutr Cancer; 1999; 33(2):125-31. PubMed ID: 10368806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Resveratrol causes WAF-1/p21-mediated G(1)-phase arrest of cell cycle and induction of apoptosis in human epidermoid carcinoma A431 cells.
    Ahmad N; Adhami VM; Afaq F; Feyes DK; Mukhtar H
    Clin Cancer Res; 2001 May; 7(5):1466-73. PubMed ID: 11350919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iressa strengthens the cytotoxic effect of docetaxel in NSCLC models that harbor specific molecular characteristics.
    Rosetti M; Zoli W; Tesei A; Ulivi P; Fabbri F; Vannini I; Brigliadori G; Granato AM; Amadori D; Silvestrini R
    J Cell Physiol; 2007 Sep; 212(3):710-6. PubMed ID: 17458894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nuclear factor-kappaB inhibition by parthenolide potentiates the efficacy of Taxol in non-small cell lung cancer in vitro and in vivo.
    Zhang D; Qiu L; Jin X; Guo Z; Guo C
    Mol Cancer Res; 2009 Jul; 7(7):1139-49. PubMed ID: 19584264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of apoptotic effects induced by resveratrol, dibenzoylmethane, and their analogues on human lung carcinoma cells.
    Weng CJ; Yang YT; Ho CT; Yen GC
    J Agric Food Chem; 2009 Jun; 57(12):5235-43. PubMed ID: 19441815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resveratrol induces prostate cancer cell entry into s phase and inhibits DNA synthesis.
    Kuwajerwala N; Cifuentes E; Gautam S; Menon M; Barrack ER; Reddy GP
    Cancer Res; 2002 May; 62(9):2488-92. PubMed ID: 11980638
    [TBL] [Abstract][Full Text] [Related]  

  • 19. G2/M cell cycle arrest and induction of apoptosis by a stilbenoid, 3,4,5-trimethoxy-4'-bromo-cis-stilbene, in human lung cancer cells.
    Lee EJ; Min HY; Joo Park H; Chung HJ; Kim S; Nam Han Y; Lee SK
    Life Sci; 2004 Oct; 75(23):2829-39. PubMed ID: 15464834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-agent molecular targeting of the epidermal growth factor receptor (EGFR): combining anti-EGFR antibody with tyrosine kinase inhibitor.
    Huang S; Armstrong EA; Benavente S; Chinnaiyan P; Harari PM
    Cancer Res; 2004 Aug; 64(15):5355-62. PubMed ID: 15289342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.